Hester Biosciences Limited (IN:HESTERBIO)
:HESTERBIO
Want to see IN:HESTERBIO full AI Analyst Report?
Total Valuation
Hester Biosciences Limited has a market cap or net worth of ₹17.60B. The enterprise value is ₹19.38B.
Market Cap₹17.60B
Enterprise Value₹19.38B
Share Statistics
Hester Biosciences Limited has 8,506,865 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding8,506,865
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Hester Biosciences Limited’s return on equity (ROE) is 0.15 and return on invested capital (ROIC) is 8.23%.
Return on Equity (ROE)0.15
Return on Assets (ROA)0.08
Return on Invested Capital (ROIC)8.23%
Return on Capital Employed (ROCE)0.13
Revenue Per Employee5.18M
Profits Per Employee866.65K
Employee Count642
Asset Turnover0.49
Inventory Turnover2.25
Valuation Ratios
The current PE Ratio of Hester Biosciences Limited is 30.3. Hester Biosciences Limited’s PEG ratio is 0.17.
PE Ratio30.3
PS Ratio3.12
PB Ratio2.88
Price to Fair Value2.88
Price to FCF24.86
Price to Operating Cash Flow96.50
PEG Ratio0.17
Income Statement
In the last 12 months, Hester Biosciences Limited had revenue of 3.33B and earned 556.39M in profits. Earnings per share was 67.57.
Revenue3.33B
Gross Profit1.69B
Operating Income677.77M
Pretax Income758.36M
Net Income556.39M
EBITDA866.58M
Earnings Per Share (EPS)67.57
Cash Flow
In the last 12 months, operating cash flow was 174.78M and capital expenditures -83.72M, giving a free cash flow of 91.06M billion.
Operating Cash Flow174.78M
Free Cash Flow91.06M
Free Cash Flow per Share10.70
Dividends & Yields
Hester Biosciences Limited pays an annual dividend of ₹7, resulting in a dividend yield of 0.44%
Dividend Per Share₹7
Dividend Yield0.44%
Payout Ratio13.58%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.54
52-Week Price Change14.45%
50-Day Moving Average1.73K
200-Day Moving Average1.68K
Relative Strength Index (RSI)64.21
Average Volume (3m)308.00
Important Dates
Hester Biosciences Limited upcoming earnings date is Aug 12, 2026, TBA (Confirmed).
Last Earnings DateMay 15, 2026
Next Earnings DateAug 12, 2026
Ex-Dividend Date―
Financial Position
Hester Biosciences Limited as a current ratio of 1.37, with Debt / Equity ratio of 54.07%
Current Ratio1.37
Quick Ratio0.89
Debt to Market Cap0.18
Net Debt to EBITDA2.22
Interest Coverage Ratio6.20
Taxes
In the past 12 months, Hester Biosciences Limited has paid 183.52M in taxes.
Income Tax183.52M
Effective Tax Rate0.24
Enterprise Valuation
Hester Biosciences Limited EV to EBITDA ratio is 14.18, with an EV/FCF ratio of 29.46.
EV to Sales3.69
EV to EBITDA14.18
EV to Free Cash Flow29.46
EV to Operating Cash Flow20.64
Balance Sheet
Hester Biosciences Limited has ₹281.58M in cash and marketable securities with ₹2.14B in debt, giving a net cash position of -₹1.85B billion.
Cash & Marketable Securities₹281.58M
Total Debt₹2.14B
Net Cash-₹1.85B
Net Cash Per Share-₹218.01
Tangible Book Value Per Share₹434.86
Margins
Gross margin is 62.66%, with operating margin of 20.38%, and net profit margin of 16.73%.
Gross Margin62.66%
Operating Margin20.38%
Pretax Margin22.80%
Net Profit Margin16.73%
EBITDA Margin26.05%
EBIT Margin20.38%
Analyst Forecast
The average price target for Hester Biosciences Limited is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast6.91%
EPS Growth Forecast104.46%